Case Study: GSK ISS achieves faster decision-making and resource efficiencies with Anaqua's ideaPoint

GSK ISS Leverages ideaPoint, Gaining Critical Time and Resource Efficiencies

GlaxoSmithKline’s Investigator‑Sponsored Studies (ISS) program supports external investigator‑initiated clinical research but was facing growing operational strain as requests surged—reaching roughly 70 studies per team—and were managed across multiple disparate systems and informal channels (faxes, email). That fragmentation caused delays, inconsistent data, weakened communications with investigators, and challenges around security, process standardization, and global visibility.

GSK implemented ideaPoint, a secure, enterprise‑scale study management platform, to consolidate data, standardize workflows, and enable role‑based access. The solution migrated multiple repositories, retired legacy systems, and delivered faster decision making, comprehensive reporting and visibility into engagement metrics, and strengthened compliance—driving measurable efficiencies and improved investigator relationships across vaccines, oncology and other therapeutic areas.

GSK ISS